Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Precision for Medicine does not develop its own therapeutics but provides integrated CRO/lab/data/manufacturing services that accelerate drug development. Over seventy percent of their trials are in oncology with more than half in early-phase development. They have supported over fifty hematology/oncology programs including complex Phase I immuno-oncology and autologous cell therapy projects. Their biobank contains over ten million biospecimens supporting translational research globally.
Pipeline-related fields: As a CRO/service provider rather than a drug developer, they do not have an internal therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Precision for Medicine.